Did you miss the award-winning science of SIR 2025?
T
he SIR Annual Scientifi c Meeting provides the latest and most engaging scientifi c literature each year. Of this literature,
several abstracts are highlighted for their quality, data and impact. SIR Today spoke to the authors behind this science, diving deeper into their research and fi nding out what comes next. If you missed our coverage during SIR 2025, you can still read these interviews any time at
sirweb.org/ sirtoday/2025-science.
A novel IR solution for aggressive brain cancer Inside the preliminary results of the FRONTIER Trial, a fi rst-in-man study evaluating the safety and feasibility of intra-arterial Y-90 microsphere therapy as an endovascular radiotherapy for patients with recurrent GBM.
New study shows robotic- assisted ablation quick, eff ective and easy to learn One institution’s experience utilizing robotic-assisted ablation showed that after a short learning curve, physicians were able to conduct abdominal ablations more quickly and with minimal probe adjustment—and navigate complex lesions with ease.
Utilizing IR techniques to deliver immune modulating nanoparticles for HCC A new study evaluating the use of intra-arterial administration of immune modulating nanoparticles to tumors in rats indicates promising results for anew area of interventional oncology.
A cost-eff ective solution for no-option CLTI Transcatheter arterialization of the deep veins (TADV) for no-option patients with chronic limb-threatening ischemia (CLTI) is both a clinically and cost-eff ective therapy, according to a recent cost- analysis study.
New abstracts provide early data from National Cholangioscopy Registry Two abstracts detail the safety and effi cacy of various percutaneous cholangioscopy procedures in biliary disease management.
Utilizing magnetic nanoparticles and hyperthermia in a rat pancreatic cancer model Applying iron oxide nanoparticles during treatment for pancreatic cancer may increase drug effi cacy and create antitumor eff ects.
A new ablation technique for prostate cancer is seeing international success Transperineal focal laser ablation may be a safe, durable and cost-eff ective option for patients with organ-confi ned prostate cancer.
22 IRQ | SPRING 2025
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
